Germany: Tapentadol prolonged-release (PR) is a useful strong analgesic to improve pain intensity, physical functioning and quality of life in elderly osteoarthritis (OA) patients, according to a recent study published in the journal Pain Management.
Osteoarthritis is a painful and debilitating disease of joints. It affects the entire joint, involving the cartilage, joint lining, ligaments, and bone. Pain and disability is the hallmark of osteoarthritis and it has become one of the leading cause of disability in older adults, affecting 9.6% of elderly men and 18% of elderly women. OA pain leads to severe impairments in physical functioning and quality of life.
Christian Elling, Grünenthal GmbH, Aachen, Germany, and colleagues extracted data of patients with severe chronic knee and/or hip OA pain from the database of a prospective, noninterventional trial to assess the benefits of tapentadol prolonged-release in elderly patients (>65 years of age; n = 1162) compared with younger patients (≤65 years of age; n = 498).
Pain was assessed by the Numerical Rating Scale (scores 0-10, with 10 being worst pain). QoL was assessed by the Short Form-12 (scores 0-100, with 100 being least disabled).
Key findings of the study include:
53.5% of the elderly at baseline had been in pain for >2 years vs 49% of nonelderly.
After 3 months of treatment with tapentadol PR:
Pain was reduced by 3.8 points in elderly (52.1%) and 4 points in nonelderly patients (54.8%).
QoL (physical component) rose by 11.8 points in elderly and 12.3 points in nonelderly patients.
QoL (mental component) rose by 12.4 points in elderly and 13.5 points in nonelderly patients.
AEs occurred in 2.4% of elderly and 3.4% of nonelderly patients.
"Tapentadol PR is tied to reduced pain and improved QoL with a low rate of adverse events (AEs) in elderly patients with osteoarthritis (OA)," concluded the authors.
The study, "Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of life," is published in the journal Pain Management.
DOI: https://doi.org/10.2217/pmt-2019-0041
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!